Lantern Pharma (LTRN) Change in Cash (2019 - 2026)
Lantern Pharma's (LTRN) quarterly Change in Cash came in at $494958.0 in Q1 2026, up 143.67% YoY from $203128.7 in Q1 2025, and up 112.48% on a QoQ basis from -$4.0 million in Q4 2025.
Lantern Pharma (LTRN) Change in Cash (2019 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 8 years of Change in Cash data on file, last reported at $494958.0 in Q1 2026.
- Quarterly Change in Cash rose 143.67% year-over-year to $494958.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 87.81% YoY) and the FY2025 annual result came in at -$3.1 million, up 78.59% from the prior year.
- Change in Cash grew to $494958.0 in Q1 2026, from -$4.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.3 million in Q3 2025 to a low of -$5.4 million in Q2 2024.
- A 5-year average of -$2.8 million and a median of -$3.6 million in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 147.77% in 2025, down 570.34% in 2025.
- Tracing LTRN's Change in Cash over 5 years: stood at -$2.1 million in 2022, then sank by 76.74% to -$3.6 million in 2023, then jumped by 83.72% to -$591740.0 in 2024, then slumped by 570.34% to -$4.0 million in 2025, then jumped by 112.48% to $494958.0 in 2026.
- The last three Change in Cash figures came in at $494958.0 (Q1 2026), -$4.0 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Lantern Pharma | 26.05 Mn | 26.05 Mn | - | 494,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494,958.00 |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | -316,194.00 |
| Mar 31, 2025 | -1.13 Mn |
| Dec 31, 2024 | -591,740.00 |
| Sep 30, 2024 | -4.87 Mn |
| Jun 30, 2024 | -5.38 Mn |
| Mar 31, 2024 | -3.58 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | -3.39 Mn |
| Jun 30, 2023 | -4.06 Mn |
| Mar 31, 2023 | -4.72 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -4.10 Mn |
| Jun 30, 2022 | -3.29 Mn |
| Mar 31, 2022 | -5.33 Mn |
| Dec 31, 2021 | -3.14 Mn |
| Sep 30, 2021 | -5.69 Mn |
| Jun 30, 2021 | -20.02 Mn |